5% stakes
Ikarian Capital
Institution
- 5% stake reports
- 36
- 5% stake stocks
- 21
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| CNS Pharmaceuticals CNSP08/14 | 9.9%147,290 sh | +4.2pp |
| Connect Biopharma Holdings CNTB08/14 | 6.9%4,338,534 sh | −1.9pp |
| Quince Therapeutics QNCX08/14 | 9%91,789 sh | First report |
| Tenax Therapeutics TENX08/14 | 2.9%1,080,700 sh | −3.8pp |
| InMed Pharmaceuticals INM08/14 | 4.2%137,634 sh | First report |
| Kazia Therapeutics KZIA08/14 | 4.9%575,778 sh | −0.2pp |
| Lipocine LPCN05/15 | 6.3%508,556 sh | First report |
| Karyopharm Therapeutics KPTI05/15 | 0%0 sh | First report |
| Spruce Biosciences SPRB05/07 | 4.8%121,356 sh | −6.6pp |
| CNS Pharmaceuticals CNSP04/17 | 5.7%45,830 sh | First report |
| Tenax Therapeutics TENX04/07 | 6.7%1,145,100 sh | −8.8pp |
| Damora Therapeutics DMRA03/06 | 0.6%335,710 sh | −20.9pp |
| Kazia Therapeutics KZIA02/17 | 5.1%580,754 sh | First report |
| NextCure NXTC02/17 | 9.99%363,035 sh | First report |
| Glucotrack GCTK02/17 | 4.5%45,830 sh | First report |
| Connect Biopharma Holdings CNTB02/17 | 8.8%4,933,086 sh | First report |
| Alpha Cognition ACOG02/17 | 4.9%1,056,259 sh | −1.1pp |
| Pelthos Therapeutics PTHS02/17 | 8.4%255,758 sh | +2.3pp |
| Avenue Therapeutics ATXI02/17 | 4.1%130,820 sh | −2.7pp |
| Quoin Pharmaceuticals QNRX02/06 | 12.6%211,538 sh | −12.6pp |
